ClinicalTrials.Veeva

Menu

Study of Compound Nanxing Zhitong Ointment in the Treatment of Chronic Pain in Musculoskeletal System

J

Jiangsu Kanion Pharmaceutical

Status

Completed

Conditions

Chronic Primary Musculoskeletal Pain

Treatments

Other: Do not use any other similar proprietary medicines or traditional Chinese medicines.
Drug: Compound Nanying zhitong Ointment

Study type

Observational

Funder types

Industry

Identifiers

NCT07200362
CYZZ2038026 SU

Details and patient eligibility

About

A prospective cohort study on the treatment of chronic pain in the musculoskeletal system with Compound Nanxing Pain Relief Ointment. This study adopted an observational research design. Through a cohort study, patient medical records were collected to meet the criteria of chronic pain classification in International Classification of Diseases 11th Revision (ICD-11), which is located in the musculoskeletal system and occurs in the neck and shoulders, waist and back, limbs, and meets the diagnostic criteria of "cold syndrome" in traditional Chinese medicine. The target population was selected to evaluate the clinical effects of Compound Nanxing Pain Relief Ointment in treating chronic pain in the musculoskeletal system, reducing pain, improving muscle and bone function status, and enhancing quality of life. The study aimed to compare the heterogeneity of the clinical effects of Compound Nanxing Pain Relief Ointment in treating chronic pain in the musculoskeletal system. The study plan included 3000 patients, and no intervention in treatment and medication was provided to the patients during the observation period. The shortest medication duration was 2 weeks, and the longest observation period was 3 months.

Enrollment

3,029 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

For those who visit the orthopedics department, rheumatology department, or pain clinic:

  1. Those whose pain is located in the musculoskeletal system as classified in International Classification of Diseases 11th Revision(ICD-11) for chronic pain, and occurs in the neck, shoulders, waist, back, or limbs;
  2. Those who meet the diagnostic criteria of "cold syndrome" in traditional Chinese medicine, and their chronic pain worsens or occurs when exposed to cold;
  3. Those with continuous or intermittent pain lasting more than 3 months, and without surgical indications.

Exclusion criteria

None

Trial design

3,029 participants in 2 patient groups

exposed group
Description:
Use Compound Nanying zhitong Ointment alone, or use it in conjunction with conventional Western medicine treatment, without using any other similar Chinese patent medicines or traditional Chinese medicines.
Treatment:
Drug: Compound Nanying zhitong Ointment
The non-exposure group
Description:
Do not use any other similar proprietary medicines or traditional Chinese medicines.
Treatment:
Other: Do not use any other similar proprietary medicines or traditional Chinese medicines.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems